Best Lymph Node Biopsy or Excision Doctors in Brooklyn, NY

My goals are to educate you and your family about your problem and fully explain the operative and non-operative options you have to treat your condition. I am always available to my patients and our team works tirelessly to keep access and the lines of communication open. Being presented with the diagnosis of a brain tumor can be stressful, and we work hard to ensure your time with us is useful, educational, and compassionate.

Dr. Gudis is dual-fellowship trained both in Rhinology: Advanced Endoscopic Sinus and Skull Base Surgery and in Pediatric Otolaryngology. Dr. Gudis treats the full spectrum of sinonasal disorders in both adults and children as well as the full spectrum of pediatric otolaryngology.

Dr. Salvatore Caruana is the Director of the Division of Head and Neck Surgery in the Department of Otolaryngology-Head and Neck Surgery at NewYork-Presbyterian Hospital Columbia University Medical Center. He is a widely respected head and neck surgeon in the forefront of the surgical treatment of tumors of the mouth pharynx, larynx and sinuses, parathyroid surgery, thyroid gland, and salivary glands. He is a pioneer in laser microsurgery for pharyngeal and laryngeal cancers. Dr. Caruana is an Associate Clinical Professor of Otolaryngology and Head and Neck Surgery at the Columbia University College of Physicians and Surgeons. Dr. Caruana graduated cum laude from the University of Buffalo and completed his Doctor of Medicine at Mount Sinai School of Medicine. His general surgery training at St. Vincent's Hospital and Medical Center was followed by a residency in Otolaryngology at New York Eye and Ear Infirmary. He then completed an NIH funded two-and-a-half-year fellowship in Head and Neck Surgical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Caruana's peer-reviewed research has included work centering upon the biological nature of several head and neck cancers and on the role of viruses in malignancies of the paranasal sinuses.

Dr. Anas Rameau is an attending laryngologist at the Institute, and an Assistant Professor of Otolaryngology at Weill Cornell Medical College. She is a fellowship-trained otolaryngologist-head and neck surgeon, with advanced expertise in the evaluation and treatment of swallowing disorders, encompassing esophageal stenosis, gastro-esophageal reflux, dysmotility, sequelae of head and neck and thoracic radiation, Zenker's diverticulum and age-related dysphagia. She also has specialized training in the management of chronic cough, treatment of benign diseases and malignant tumors of the larynx, voice restoration, and airway rehabilitation surgery. Prior to joining the Institute, Dr. Rameau was an otolaryngology resident at Stanford University and then a fellow at UC Davis Medical School, under the mentorship of Peter Belafsky, MD MPH PhD.Dr. Rameau's clinical goals is to provide expert and compassionate care for patients with dysphagia both in the clinic and in the operating room, and to restore patients' swallowing function via advanced diagnostics technology, as well as refined endoscopic and surgical treatments. Her research focus is on outcomes studies of interventions for swallowing disorders, as well as preventative and restorative measures to decrease aspiration risk in patients with dementia. She is developing expertise in the use of artificial intelligence in the diagnostic streamlining of laryngological and swallowing disorders. In addition, Dr. Rameau is passionate about global health, and has maintained an active relationship with the Otolaryngology Department at the University of Zimbabwe in Harare. Dr. Rameau is a Diplomate of the American Board of Otolaryngology.

Dr. Matthew Mori, MD is an Otolaryngology (Ear, Nose /amp Throat) Specialist who practices in New York, NY. He is 48 years old and has been practicing for 16 years. Dr. Matthew Mori, MD is affiliated with Mount Sinai Morningside.

Dr. Michael A. Palese is the Chairman of Urology at Mount Sinai Beth Israel and the Director of Minimally Invasive Surgery for the Mount Sinai Health System. He specializes in robotic, laparoscopic, and endoscopic surgery. Dr. Palese earned his Doctor of Medicine from the Icahn School of Medicine at Mount Sinai. He completed his residency in urology at the University of Maryland and a fellowship in robotic and laparoscopic surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. As a board-certified urologist and fellowship-trained surgeon, he is an expert in diagnosing and treating kidney, ureter, adrenal, bladder, and prostate diseases, with a special emphasis on minimally invasive surgery. He is a leading authority in the research and treatment of kidney disease, particularly kidney cancer and kidney stones. Among a select group of surgeons in the United States trained in open, laparoscopic, and robotic surgery, he has performed over 3,000 kidney procedures using these techniques. Dr. Palese is a world-recognized surgeon and scholar, as well as a pioneer in developing new treatments and technologies. He performed the first robotic radical nephrectomy, robotic partial nephrectomy, robotic donor nephrectomy, robotic nephroureterectomy, robotic adrenalectomy, and robotic ureteral reimplantation and reconstruction at The Mount Sinai Medical Center in New York City. He also holds several patents for novel surgical device designs. He operates at Mount Sinai Hospital and Mount Sinai Beth Israel Hospital. His offices are located at 625 Madison Avenue, 2nd Floor, and 10 East Union Square, Suite 3A.

Dr. Raymond Chai, MD is an Otolaryngology (Ear, Nose /amp Throat) Specialist who practices in New York, NY. He is 45 years old and has been practicing for 18 years. Dr. Raymond Chai, MD is affiliated with Mount Sinai Morningside.

Dr. Raymond Chai, MD is an Otolaryngology (Ear, Nose /amp Throat) Specialist who practices in New York, NY. He is 45 years old and has been practicing for 18 years. Dr. Raymond Chai, MD is affiliated with Mount Sinai Morningside.

Dr. Jennifer Lehman, MD is a Critical Care Surgery Specialist who practices in New York, NY. She is 52 years old and has been practicing for 21 years. Dr. Jennifer Lehman, MD is affiliated with Mount Sinai Morningside.

I am a board-certified general surgeon and surgical oncologist with a clinical expertise in melanoma and soft tissue sarcoma. I work closely with the patient and the comprehensive team of physicians to customize treatment plans for each individual. In my research, I am investigating new ways to allow the immune system to fight cancer. I am also involved in clinical trials aimed at defining the role of current therapies and improving outcomes through novel new treatments. I am fluent in both Spanish and English.

I am a surgical oncologist whose primary area of clinical and research interest is melanoma. In 1991, I introduced lymph-node mapping and sentinel lymph-node biopsy for melanoma and other selected skin cancers. Together, these procedures can determine during surgery whether a tumor has spread to surrounding lymph nodes. Using lymph node mapping, we can pinpoint the precise lymph node into which a nearby tumor is likely to travel first (called the sentinel node). If a biopsy of the sentinel node indicates cancer spread, the surrounding lymph nodes are removed. But if there is no evidence of cancer in the sentinel node, patients are spared from additional lymph node surgery. My research has focused primarily on detecting and defining the clinical significance of individual melanoma cells in the sentinel lymph nodes, blood, and bone marrow of melanoma patients, with the goal of identifying patients at highest risk of cancer recurrence following surgery to remove a melanoma. I served as Chief of the Gastric and Mixed Tumor Service in MSKCC's Department of Surgery from 1997 until October 2003. This service focuses primarily on the surgical management of less common malignancies, including melanoma, sarcoma, gastric cancer, and pancreatic cancer, and also provides surgical support for the Lymphoma Service. I currently serve as a co-leader of the MSKCC Melanoma Disease Management Team -- a multidisciplinary team of surgeons, medical oncologists, pathologists, and other medical professionals who specialize in the diagnosis and treatment of melanoma. On a national and international level, I am involved in advancing new ways to diagnose and treat melanoma as a member of the American Joint Commission on Cancer Melanoma Staging Committee, the National Comprehensive Cancer Network Melanoma Advisory Group, the American College of Surgeons Commission on Cancer Melanoma Working Group, the American College of Surgeons Oncology Group's Melanoma Working Group, and the World Health Organization Melanoma Committee. In addition to my interest in melanoma, I also have an expertise in the treatment of gastric cancer. I served on the program committee of the International Gastric Cancer National Meeting in 2001. And in 2002, I was co-leader of the Gastric Cancer Working Group of the National Cancer Institute's Stomach Cancer Progress Review Group. I am currently the co-principal investigator of two gastric cancer studies at MSKCC. The first evaluates the effectiveness of chemotherapy prior to surgery in high-risk gastric cancer patients, and the second is a 'Quality of Life Assessment' of gastric cancer patients. I am also an active member of the American College of Surgeons Oncology Group Upper GI Cancer Working Group. MSKCC plays a key role in training oncology doctors, and I have had a long-standing interest in the training of surgical oncology fellows. I served as the Director of Surgical Education for the Surgical Oncology Fellowship Training Program at MSKCC from 1991 to 1997, and I was Director of the Society of Surgical Oncology Training Committee, where I oversaw the administration of all surgical oncology fellowships across the nation from 1994 to 1999. As part of my interest in spreading information we have learned about cancer at MSKCC, I have lectured extensively, both nationally and internationally, and authored a number of manuscripts and reviews on various surgical oncology topics. You can view a complete listing of my publications in PubMed by clicking on the PubMed icon to the right.

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Lung cancer remains the number one cancer killer in the U.S. Despite this, new treatments are offering people more hope and chances for cure than ever before. As a thoracic surgeon at Weill Cornell Medicine I am fortunate to be part of a world class team of thoracic surgeons and other cancer specialists. Our goal has always been to offer our patients unrivaled cancer care, while also personalizing this to an individual patient's unique disease and personal situation. I take great pride in the care we provide our patients; and being with my patients from diagnosis, throughout treatment, and finally to cancer cure is my greatest professional joy.